COVID-19 has put vaccine efficacy under a spotlight. However, the reluctance of people to be vaccinated has postponed the end of the COVID-19 pandemic. Currently, opioid vaccines are being developed, which could help prevent opioid addiction, overdoses, or relapse in combination with medication-assisted therapy. The fear is that the uptake of opioid vaccines could be met by the same reluctance as seen with COVID-19 vaccines.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448697 | PMC |
| http://dx.doi.org/10.1016/j.tips.2022.08.010 | DOI Listing |
Publication Analysis
Top Keywords
opioid vaccines
8
lessons covid-19
4
covid-19 increase
4
opioid
4
increase opioid
4
opioid vaccine
4
vaccine acceptance
4
acceptance covid-19
4
covid-19 vaccine
4
vaccine efficacy
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!